News

New SUDEP Practice Guidelines For Clinicians and Health Professionals

National Epilepsy Week (May 15th - 21st)

Epilepsy Ireland welcomes new warnings on Irish boxes of sodium valproate (epilim)

Science Foundation Ireland has announced that it is to fund a new Research Centre which will focus on the diagnosis, monitoring and treatment of chronic and rare neurological diseases, including epilepsy.

Today the campaign group FACS Forum called on the Health Products Regulatory Authority (HPRA) to urgently ensure that the outer packaging of all products containing sodium valproate

The FACS Forum, an umbrella of patient and disability organisations including Epilepsy Ireland, is urging the government to undertake an investigation into the current and historical use of the drug sodium valproate (Epilim) in pregnant women,

A new study in the Annals of Neurology identified which drugs will be most effective to help children with childhood absence epilepsy (CAE).

The International League Against Epilepsy (ILAE) has recently revised its classification of seizures. The update, the first in 30 years, includes many types of seizures not captured in the older version, allowing doctors and patients to make more informed decisions concerning treatment.

The HSE has accepted Briviact (brivaracetam) for use within Ireland as an add-on treatment for partial onset seizures (POS), with or without secondary generalised seizures in adults with epilepsy (aged 16 years and older).

Thank you for supporting Purple Day